Cargando…
Impact of COVID-19 on autoimmune blistering diseases
Since the beginning of the COVID-19 outbreak, attention has gradually moved from the respiratory manifestations of the disease toward its dermatologic aspects. The need for wearing personal protective measures and their cutaneous side effects, detection of related or specific COVID-19 skin eruptions...
Autores principales: | Drenovska, Kossara, Vassileva, Snejina, Tanev, Ivan, Joly, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955939/ https://www.ncbi.nlm.nih.gov/pubmed/34517993 http://dx.doi.org/10.1016/j.clindermatol.2021.01.007 |
Ejemplares similares
-
Autoimmune connective tissue diseases in the COVID-19 pandemic
por: Dourmishev, Lyubomir, et al.
Publicado: (2021) -
Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
por: Vassileva, Snejina, et al.
Publicado: (2021) -
Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
por: Drenovska, Kossara, et al.
Publicado: (2022) -
Commentary: COVID-19 pandemic — 1 Year later
por: Drenovska, Kossara, et al.
Publicado: (2021) -
Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy
por: Drenovska, Kossara, et al.
Publicado: (2023)